Indications |
Oral Urinary tract infections, Otitis media, Chlamydial infections, Prophylaxis of meningococcal meningitis Adult: Initially, 2 g followed by 1 g bid. Severe infections: 1 g tid. Child: Initially, 50-60 mg/kg, followed by 25-30 mg/kg bid. Max daily dose: 75mg/kg. Renal impairment: Dose reduction in renal impairment Special Populations: Dose reduction in renal impairment. |
Contraindications |
Severe renal or hepatic impairment, blood disorders, hypersensitivity to sulfonamides, porphyria, SLE, infants <2 mth, pregnancy (3rd trimester) and lactation. |
Warnings / Precautions |
Renal or hepatic impairment, history of allergy or asthma, AIDS, G6PD deficiency, elderly, ensure adequate fluid intake to reduce risk of crystalluria. Pregnancy. |
Adverse Reactions |
Nausea, vomiting, anorexia, diarrhoea, hypersensitivity reactions, blood disorders, serum sickness-like syndrome, hypoglycaemia, hypothyroidism, pseudomembranous colitis, kernicterus in premature neonates. |
Drug Interactions |
Concurrent use increases phenytoin and methotrexate levels; increased risk of bleeding with warfarin and acenocoumarol; may potentiate antidiabetic effect of sulphonylureas. Potentially Fatal: Concurrent use increased risk of blood dyscrasias with clozapine and pyrimethamine. See Below for More sulfamethoxazole Drug Interactions |
Lab Interactions |
Interference with tests for urea, creatinine, urinary glucose, urobilinogen. |
Mechanism of Actions |
Sulfamethoxazole is an intermediate-acting sulfonamide which interferes with the synthesis of nucleic acids in sensitive organisms by blocking the conversion of PABA to the coenzyme dihydrofolic acid. Its action is bacteriostatic, although it can be bactericidal where concentrations of thymine are low in the surrounding medium. It has broad spectrum of action though its usefulness has been greatly reduced by widespread resistance. |
Administration |
Should be taken on an empty stomach (i.e. At least one hour before food or two hours after food). |
ATC Classification |
J01EC01 - sulfamethoxazole ; Belongs to the class of intermediate-acting sulfonamides. Used in the systemic treatment of infections. |
Available As |
|
Sulphamethoxazole
Post Review about Sulphamethoxazole Click here to cancel reply.
Sulphamethoxazole Containing Brands
Sulphamethoxazole is used in following diseases
Drug - Drug Interactions of Sulphamethoxazole
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.